Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $512.92 ($4.3M) on 2026-08-06, disclosed to the SEC on 2026-08-06.
Scheduled sale ($4.3M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $512.92 | 760 | $390K | 9.1% |
| 2 | $514.82 | 1,795 | $924K | 21.5% |
| 3 | $515.93 | 1,360 | $702K | 16.4% |
| 4 | $516.93 | 1,617 | $836K | 19.5% |
| 5 | $517.94 | 780 | $404K | 9.4% |
| 6 | $518.82 | 360 |
| $187K |
| 4.4% |
| 7 | $521.50 | 1,308 | $682K | 15.9% |
| 8 | $522.39 | 320 | $167K | 3.9% |
| Total | $517.05 avg | 8,300 | $4.3M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-07-16 | $4.4M | — | Filing → |